SMOKE#SCREEN uses fake Adobe and Zoom updates, document lures, and trusted cloud services to install ScreenConnect for persistent remote access.

CMS is proposing a Medicare payment ban for remote patient monitoring services delivered by third-party vendors. Here are six things to know: 1. The proposed rule, released July 14 as part of the 2027 ...

Discover What’s Streaming On: If your Friday night routine usually includes catching up on the week’s biggest political headlines with Bill Maher, you’ll have to hit pause for a few weeks. Real Time ...

New research using smartwatches shows that older adults can accurately assess how well they are thinking in the moment. The study finds their self-ratings closely match actual cognitive performance.

Milwaukee health officials are in communication with three people who recently traveled to the city from central Africa, where a fast-growing Ebola outbreak has infected more than 1,000 people. The ...

Your county tax office isn’t open after hours. Neither is your local DMV. And that’s OK. But a government agency responsible for monitoring people accused of murder and capital murder shouldn’t keep ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

The agency announced that it has completed the first tests of a system that allows FDA scientists to see safety and effectiveness data from patients as it is collected, turning the traditional process ...

Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.